吡咯烷-1-羧酰胺氢溴酸 | 175277-39-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 吡咯烷-1-羧酰胺氢溴酸
• 英文名称: 1-pyrrolidinylcarbamidine hydrobromide
• 英文别名: 1-pyrrolidinecarboximidamide hydrobromide；Pyrrolidine-1-carboximidamide hydrobromide；pyrrolidine-1-carboximidamide;hydrobromide
• CAS: 175277-39-1
• 化学式: BrH*C₅H₁₁N₃
• 分子量: 194.074
• InChiKey: NGHBTEAGXBELKR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.55
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  53.1
• 氢给体数：
  3
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38,R
• 海关编码：
  2933990090
• 安全说明：
  S26,S36/37/39

SDS

Name:	Pyrrolidine-1-carboximidamide hydrobromide 97% Material Safety Data Sheet
Synonym:	Pyrrolidinoformamidine hydrobromid
CAS:	175277-39-1

Section 1 - Chemical Product MSDS Name:Pyrrolidine-1-carboximidamide hydrobromide 97% Material Safety Data Sheet
Synonym:Pyrrolidinoformamidine hydrobromid

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
175277-39-1	Pyrrolidine-1-carboximidamide hydrobro	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 175277-39-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H12BrN3
Molecular Weight: 194

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, bases.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 175277-39-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Pyrrolidine-1-carboximidamide hydrobromide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 175277-39-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 175277-39-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 175277-39-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  丙二酸二乙酯 、 吡咯烷-1-羧酰胺氢溴酸 在 sodium 作用下， 以 乙醇 为溶剂， 以99%的产率得到2-(1-pyrrolidinyl)-4,6-pyrimidinediol
  参考文献：
  名称：

  [EN] ANTIVIRAL PYRIMIDINES
  [FR] PYRIMIDINES ANTIVIRALES

  摘要：

  公开号：

  WO2010118367A3
• 作为产物：
  描述：

  四氢吡咯 、 2-乙基-2-异硫脲 以 水 为溶剂， 以100%的产率得到吡咯烷-1-羧酰胺氢溴酸
  参考文献：
  名称：

  [EN] ANTIVIRAL PYRIMIDINES
  [FR] PYRIMIDINES ANTIVIRALES

  摘要：

  公开号：

  WO2010118367A3

文献信息

• Syntheses Based on 4-Chloro-1-[3,5-di(trifluoromethyl)phenyl]-, 4-Chloro-1-(2,4-difluorophenyl)-5-formyl-3-methyl-6,7-dihydroindazoles, and 4-Chloro-5-formyl-3-methyl-1-(2-pyridyl)-6,7-dihydroindazoles
  作者：I. Strakova、A. Strakovs、M. Petrova

  DOI：10.1007/s10593-005-0196-2

  日期：2005.5
• Pyrazolo[5,4-h]quinazolines
  作者：I. A. Strakova、A. Ya. Strakov、M. V. Petrova

  DOI：10.1007/bf02256921

  日期：2000.7
• [EN] ANTIVIRAL PYRIMIDINES<br/>[FR] PYRIMIDINES ANTIVIRALES
  申请人：PROGENICS PHARM INC

  公开号：WO2010118367A3

  公开（公告）日：2011-03-10